Use

The Pseudocholinesterase phenotype can be determined by analysis of Pseudocholinesterase activity and percent inhibition by dibucaine. Approximately 96% of the population has normal activity; around 4% exhibit decreased activity leading to prolonged paralysis following succinylcholine administration, and about 1 in 3,000 patients experience severe, prolonged paralysis following anesthetic exposure.